Genetics and Pathophysiology of Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.
Level 5 - mechanism / opinion, no new human data
Narrative review of disease genetics and pathophysiology without original empirical data or systematic search methods.
PubMed 39836621 · doi:10.1210/clinem/dgae535
What was done
Narrative review summarizing the genetic basis (CYP21A2 mutations), clinical classification (salt-wasting, simple virilizing, nonclassic), and pathophysiology of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
What was found
The classic form occurs in approximately 1 in 16,000 births. Cortisol deficiency removes negative feedback on the hypothalamic-pituitary-adrenal axis, elevating ACTH and adrenal androgens, which accelerates skeletal maturation and causes premature epiphyseal closure. Additionally, supraphysiologic glucocorticoid replacement used to suppress androgens adversely affects final adult height. No original experimental data or statistical comparisons are reported.
Why it matters
The review synthesizes the pathophysiological basis of classic 21-hydroxylase deficiency and highlights the clinical challenge of managing androgen excess without compromising linear growth via glucocorticoid overexposure.
Limits
As a narrative review, it presents no original clinical data, systematic search strategy, or meta-analytic pooling. Specific effect sizes, treatment outcomes, and genotype-phenotype correlation statistics are absent from the abstract.